The fecal occult blood test (FOBT) is a noninvasive screening tool used to detect small, often invisible amounts of blood in the stool. Blood in the stool can be an early warning sign of colorectal cancer, colon polyps, or other gastrointestinal (GI) conditions such as ulcers, diverticulosis, or inflammatory bowel disease. The hybrid test combines two types of FOBTs: the guaiac-based test (gFOBT) and the fecal immunochemical test (FIT), enhancing the chances of detecting blood from a wider range of sources.
The FIT portion of the hybrid test uses antibodies to specifically detect human hemoglobin, the oxygen-carrying protein in red blood cells. FIT is highly sensitive to bleeding that occurs in the lower part of the colon or rectum, where most colorectal cancers develop. It does not require dietary restrictions and tends to have fewer false positives because it doesn’t react to non-human blood or food components.
The guaiac-based FOBT detects the peroxidase activity of hemoglobin, which causes a color change on a special test card when blood is present. This method can detect bleeding from anywhere in the GI tract but is less specific, and results can be affected by eating a lot of red meat, or medications such as NSAIDs (nonsteroidal anti-inflammatory drugs).
By combining these two approaches in a hybrid test, clinicians gain the advantages of both: the specificity and convenience of FIT, plus the broader detection range of gFOBT. This may increase the chances of identifying bleeding that would otherwise go unnoticed by using just one method. However, it also means there is a higher likelihood of false positives, so further testing, such as colonoscopy or upper endoscopy, is usually needed if the result comes back positive.
This hybrid test can be especially useful when you have a history of unexplained GI symptoms or when a more comprehensive screen is desired. Still, no fecal occult test can pinpoint the exact cause or location of bleeding, which is why follow-up is so important.